Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Lyell Immunopharma PE Ratio 2020-2024 | LYEL

Current and historical p/e ratio for Lyell Immunopharma (LYEL) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lyell Immunopharma PE ratio as of December 25, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
  
Lyell Immunopharma PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-12-24 0.61 0.00
2024-09-30 1.38 $-0.79 0.00
2024-06-30 1.45 $-0.82 0.00
2024-03-31 2.23 $-0.90 0.00
2023-12-31 1.94 $-0.93 0.00
2023-09-30 1.47 $-0.76 0.00
2023-06-30 3.18 $-0.84 0.00
2023-03-31 2.36 $-0.73 0.00
2022-12-31 3.47 $-0.74 0.00
2022-09-30 7.33 $-0.89 0.00
2022-06-30 6.52 $-0.81 0.00
2022-03-31 5.05 $-2.13 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.179B $0.000B
Lyell Immunopharma Inc. is a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors. Lyell Immunopharma Inc. is based in SOUTH SAN FRANCISCO, Calif.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $74.307B 28.59
Chugai Pharmaceutical (CHGCY) Japan $72.436B 28.22
Takeda Pharmaceutical (TAK) Japan $41.905B 8.72
Merck (MKKGY) Germany $18.621B 16.67
Sandoz Group AG (SDZNY) Switzerland $18.176B 0.00
Astellas Pharma (ALPMY) Japan $17.463B 16.08
United Therapeutics (UTHR) United States $16.111B 15.85
Summit Therapeutics (SMMT) United States $14.012B 0.00
Neurocrine Biosciences (NBIX) United States $13.823B 36.60
Shionogi (SGIOY) Japan $11.910B 11.93
Madrigal Pharmaceuticals (MDGL) United States $6.805B 0.00
Orion OYJ (ORINY) Finland $6.196B 17.42
Ionis Pharmaceuticals (IONS) United States $5.768B 0.00
Corcept Therapeutics (CORT) United States $5.466B 41.40
Crinetics Pharmaceuticals (CRNX) United States $5.002B 0.00
PTC Therapeutics (PTCT) United States $3.498B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.579B 11.69
Dyne Therapeutics (DYN) United States $2.439B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.432B 14.54
NewAmsterdam Pharma (NAMS) Netherlands $2.397B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.225B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.075B 0.00
Soleno Therapeutics (SLNO) United States $1.930B 0.00
Evotec AG (EVO) Germany $1.772B 0.00
Xencor (XNCR) United States $1.700B 0.00
Indivior (INDV) United States $1.653B 6.74
BioCryst Pharmaceuticals (BCRX) United States $1.589B 0.00
Guardian Pharmacy Services (GRDN) United States $1.401B 0.00
Ocular Therapeutix (OCUL) United States $1.310B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.286B 0.00
Harrow (HROW) United States $1.205B 0.00
Enliven Therapeutics (ELVN) United States $1.131B 0.00
ARS Pharmaceuticals (SPRY) United States $1.109B 0.00
Ardelyx (ARDX) United States $1.099B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.986B 0.00
Collegium Pharmaceutical (COLL) United States $0.937B 5.12
Bioventus (BVS) United States $0.867B 27.39
Cronos Group (CRON) Canada $0.765B 0.00
Oruka Therapeutics (ORKA) United States $0.740B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.738B 0.00
Relay Therapeutics (RLAY) United States $0.708B 0.00
USANA Health Sciences (USNA) United States $0.699B 12.95
Elite Pharmaceuticals (ELTP) United States $0.572B 0.00
Savara (SVRA) United States $0.549B 0.00
Tourmaline Bio (TRML) United States $0.549B 0.00
Altimmune (ALT) United States $0.537B 0.00
ProKidney (PROK) United States $0.519B 0.00
Xeris Biopharma Holdings (XERS) United States $0.517B 0.00
OmniAb (OABI) United States $0.498B 0.00
Verve Therapeutics (VERV) United States $0.489B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.484B 0.00
Zevra Therapeutics (ZVRA) United States $0.459B 0.00
Esperion Therapeutics (ESPR) United States $0.453B 0.00
KalVista Pharmaceuticals (KALV) United States $0.433B 0.00
Siga Technologies (SIGA) United States $0.428B 5.00
Akebia Therapeutics (AKBA) United States $0.406B 0.00
Korro Bio (KRRO) United States $0.406B 0.00
Organogenesis (ORGO) United States $0.400B 0.00
Jupiter Neurosciences (JUNS) United States $0.375B 0.00
Avita Medical (RCEL) United States $0.338B 0.00
Aquestive Therapeutics (AQST) United States $0.321B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.290B 117.43
Aldeyra Therapeutics (ALDX) United States $0.283B 0.00
Nature's Sunshine Products (NATR) United States $0.279B 16.57
Amylyx Pharmaceuticals (AMLX) United States $0.274B 0.00
4D Molecular Therapeutics (FDMT) United States $0.269B 0.00
Larimar Therapeutics (LRMR) United States $0.241B 0.00
Heron Therapeutics (HRTX) United States $0.240B 0.00
Innate Pharma SA (IPHYF) France $0.233B 0.00
Lexeo Therapeutics (LXEO) United States $0.210B 0.00
Profound Medical (PROF) Canada $0.210B 0.00
Silence Therapeutics (SLN) United Kingdom $0.210B 0.00
Aclaris Therapeutics (ACRS) United States $0.207B 0.00
Inhibikase Therapeutics (IKT) United States $0.199B 0.00
Acrivon Therapeutics (ACRV) United States $0.194B 0.00
MediWound (MDWD) Israel $0.193B 0.00
Nektar Therapeutics (NKTR) United States $0.167B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.160B 0.00
Telomir Pharmaceuticals (TELO) United States $0.147B 0.00
Metagenomi (MGX) United States $0.141B 0.00
CytoDyn (CYDY) United States $0.140B 0.00
Nanobiotix S.A (NBTX) France $0.139B 0.00
VAXART, INC (VXRT) United States $0.138B 0.00
Achieve Life Sciences (ACHV) Canada $0.130B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.129B 0.00
Inotiv (NOTV) United States $0.118B 0.00
Cassava Sciences (SAVA) United States $0.113B 0.00
Champions Oncology (CSBR) United States $0.109B 0.00
Protara Therapeutics (TARA) United States $0.107B 0.00
ElectroCore (ECOR) United States $0.107B 0.00
Cardiol Therapeutics (CRDL) Canada $0.103B 0.00
Regulus Therapeutics (RGLS) United States $0.101B 0.00
Pyxis Oncology (PYXS) United States $0.095B 0.00
Journey Medical (DERM) United States $0.094B 0.00
Fractyl Health (GUTS) United States $0.092B 0.00
Avalo Therapeutics (AVTX) United States $0.092B 0.00
Century Therapeutics (IPSC) United States $0.087B 0.00
Context Therapeutics (CNTX) United States $0.086B 0.00
Arch Biopartners (ACHFF) Canada $0.085B 0.00
Assertio Holdings (ASRT) United States $0.084B 21.90
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Karyopharm Therapeutics (KPTI) United States $0.075B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.072B 0.00
ESSA Pharma (EPIX) Canada $0.071B 0.00
Unicycive Therapeutics (UNCY) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Prelude Therapeutics (PRLD) United States $0.065B 0.00
Scienture Holdings (SCNX) United States $0.064B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.060B 0.00
OptiNose (OPTN) United States $0.057B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
AlloVir (ALVR) United States $0.055B 0.00
Galectin Therapeutics (GALT) United States $0.053B 0.00
FibroGen (FGEN) United States $0.050B 0.00
Swiftmerge Acquisition (ANNA) United States $0.048B 0.00
Iterum Therapeutics (ITRM) Ireland $0.048B 0.00
Rafael Holdings (RFL) United States $0.044B 0.00
VYNE Therapeutics (VYNE) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.044B 0.00
Nutriband (NTRB) United States $0.043B 0.00
Gain Therapeutics (GANX) United States $0.042B 0.00
Surrozen (SRZN) United States $0.040B 0.00
BioVie (BIVI) United States $0.038B 0.00
SCYNEXIS (SCYX) United States $0.038B 0.00
Tempest Therapeutics (TPST) United States $0.037B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.035B 0.00
Traws Pharma (TRAW) United States $0.035B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
Incannex Healthcare (IXHL) Australia $0.031B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.030B 0.00
DURECT (DRRX) United States $0.030B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Mannatech (MTEX) United States $0.021B 0.00
NRx Pharmaceuticals (NRXP) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
MEI Pharma (MEIP) United States $0.016B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
PolyPid (PYPD) Israel $0.014B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.011B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Viracta Therapeutics (VIRX) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
CERo Therapeutics Holdings (CERO) United States $0.009B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Dominari Holdings (DOMH) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Conduit Pharmaceuticals (CDT) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.09
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
TransCode Therapeutics (RNAZ) United States $0.002B 0.00
Phio Pharmaceuticals (PHIO) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
Molecular Templates (MTEM) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.77
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 41.18